Reza Zarnegar

8.3k total citations · 3 hit papers
77 papers, 6.7k citations indexed

About

Reza Zarnegar is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Reza Zarnegar has authored 77 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hepatology, 45 papers in Surgery and 24 papers in Molecular Biology. Recurrent topics in Reza Zarnegar's work include Liver physiology and pathology (63 papers), Pancreatic function and diabetes (29 papers) and Organ Transplantation Techniques and Outcomes (23 papers). Reza Zarnegar is often cited by papers focused on Liver physiology and pathology (63 papers), Pancreatic function and diabetes (29 papers) and Organ Transplantation Techniques and Outcomes (23 papers). Reza Zarnegar collaborates with scholars based in United States, United Kingdom and Italy. Reza Zarnegar's co-authors include George K. Michalopoulos, Marie C. DeFrances, Wendy M. Mars, Giovanni Gaudino, Radha P. Narsimhan, Luigi Naldini, Elisa Vigna, Pamela M. Lindroos, Youhua Liu and Aaron Bell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Reza Zarnegar

76 papers receiving 6.6k citations

Hit Papers

Hepatocyte growth factor (HGF) stimulates the tyrosine ki... 1991 2026 2002 2014 1991 1991 1995 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reza Zarnegar United States 41 4.4k 2.8k 2.7k 1.2k 901 77 6.7k
Wendy M. Mars United States 37 2.6k 0.6× 2.4k 0.9× 2.4k 0.9× 971 0.8× 588 0.7× 83 6.2k
Yasushi Daikuhara Japan 34 3.5k 0.8× 1.8k 0.7× 2.3k 0.9× 1.3k 1.1× 630 0.7× 79 5.2k
William C. Bowen United States 33 2.8k 0.6× 2.1k 0.7× 2.5k 0.9× 836 0.7× 516 0.6× 66 5.2k
Alastair J. Strain United Kingdom 42 2.1k 0.5× 1.6k 0.6× 2.1k 0.8× 815 0.7× 521 0.6× 100 5.1k
Marie C. DeFrances United States 21 2.6k 0.6× 1.5k 0.5× 1.8k 0.6× 1.2k 1.0× 433 0.5× 31 4.0k
Alessia Omenetti United States 35 1.8k 0.4× 1.9k 0.7× 1.1k 0.4× 1.8k 1.4× 447 0.5× 58 4.3k
Luke Boulter United Kingdom 22 1.8k 0.4× 1.2k 0.4× 1.5k 0.6× 1.0k 0.8× 497 0.6× 48 3.7k
Christophe Corpechot France 37 4.8k 1.1× 1.0k 0.4× 2.8k 1.0× 4.1k 3.3× 844 0.9× 115 7.9k
E M Rosen United States 28 1.4k 0.3× 1.8k 0.7× 678 0.2× 234 0.2× 784 0.9× 38 3.5k
Ingrid Laurendeau France 38 774 0.2× 2.1k 0.7× 466 0.2× 833 0.7× 619 0.7× 63 4.2k

Countries citing papers authored by Reza Zarnegar

Since Specialization
Citations

This map shows the geographic impact of Reza Zarnegar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Zarnegar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Zarnegar more than expected).

Fields of papers citing papers by Reza Zarnegar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Zarnegar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Zarnegar. The network helps show where Reza Zarnegar may publish in the future.

Co-authorship network of co-authors of Reza Zarnegar

This figure shows the co-authorship network connecting the top 25 collaborators of Reza Zarnegar. A scholar is included among the top collaborators of Reza Zarnegar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Zarnegar. Reza Zarnegar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Magda, Paul, et al.. (2021). Neurological manifestations as primary presentation of COVID‐19 in hospitalized patients. Acta Neurologica Scandinavica. 143(5). 569–574. 11 indexed citations
2.
Zarnegar, Reza, et al.. (2017). Infectious Temporal Lobe Encephalitis—Not Just Herpes!. The Neurohospitalist. 8(3). 156–157. 1 indexed citations
3.
Zarnegar, Reza, et al.. (2016). Clinical outcomes in patients with generalized periodic discharges. Seizure. 45. 114–118. 6 indexed citations
4.
Seneviratne, Danushka S., Jihong Ma, Xinping Tan, et al.. (2014). Genomic Instability Causes HGF Gene Activation in Colon Cancer Cells, Promoting Their Resistance to Necroptosis. Gastroenterology. 148(1). 181–191.e17. 40 indexed citations
5.
Ma, Jihong, Chunbin Zou, Lida Guo, et al.. (2013). Novel Death Defying Domain in Met Entraps the Active Site of Caspase-3 and Blocks Apoptosis in Hepatocytes. Hepatology. 59(5). 2010–2021. 21 indexed citations
6.
Yu, Yan, Guoying Yu, George C. Tseng, et al.. (2007). Glutathione Peroxidase 3, Deleted or Methylated in Prostate Cancer, Suppresses Prostate Cancer Growth and Metastasis. Cancer Research. 67(17). 8043–8050. 190 indexed citations
7.
Zou, Chunbin, Jihong Ma, Xue Wang, et al.. (2007). Lack of Fas antagonism by Met in human fatty liver disease. Nature Medicine. 13(9). 1078–1085. 77 indexed citations
8.
Mehdi, Haider, Susan Manzi, Purnima P. Desai, et al.. (2003). A functional polymorphism at the transcriptional initiation site in β2‐glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of β2‐glycoprotein I. European Journal of Biochemistry. 270(2). 230–238. 22 indexed citations
9.
10.
Seol, Dai‐Wu, Qiuyan Chen, Martin L. Smith, & Reza Zarnegar. (1999). Regulation of the c-met Proto-oncogene Promoter by p53. Journal of Biological Chemistry. 274(6). 3565–3572. 46 indexed citations
11.
Seol, Dai‐Wu & Reza Zarnegar. (1998). Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1395(3). 252–258. 20 indexed citations
12.
Éthier, Chantal, et al.. (1997). Hepatic expression of regeneration marker genes following partial hepatectomy in the rat. Journal of Hepatology. 26(3). 659–668. 8 indexed citations
13.
Seol, Dai‐Wu, et al.. (1997). Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines. Hepatology. 26(1). 59–66. 84 indexed citations
14.
Zarnegar, Reza. (1995). Regulation of HGF and HGFR gene expression. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 74. 33–49. 58 indexed citations
15.
Liu, Youhua, George K. Michalopoulos, & Reza Zarnegar. (1994). Structural and functional characterization of the mouse hepatocyte growth factor gene promoter.. Journal of Biological Chemistry. 269(6). 4152–4160. 137 indexed citations
16.
Liu, Youhua, Aaron Bell, George K. Michalopoulos, & Reza Zarnegar. (1994). The mouse hepatocyte growth factor-encoding gene: structural organization and evolutionary conservation. Gene. 144(2). 179–187. 14 indexed citations
17.
Lindroos, P M, et al.. (1992). Plasma levels of HGF in rats treated with tumor promoters. Carcinogenesis. 13(1). 139–141. 29 indexed citations
18.
Wolf, Helmut K., Reza Zarnegar, & George K. Michalopoulos. (1991). Localization of hepatocyte growth factor in human and rat tissues: An immunohistochemical study. Hepatology. 14(3). 488–494. 150 indexed citations
19.
Zarnegar, Reza, et al.. (1990). Identification and partial characterization of receptor binding sites for HGF on rat hepatocytes. Biochemical and Biophysical Research Communications. 173(3). 1179–1185. 58 indexed citations
20.
Zarnegar, Reza & George K. Michalopoulos. (1989). Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.. PubMed. 49(12). 3314–20. 407 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026